vimarsana.com

Latest Breaking News On - Dina radenkovic - Page 5 : vimarsana.com

A healthcare brand for women begins to take shape

At her company, Gameto, Dina Radenkovic specifically wants to build a massive healthcare business that redefines reproductive health.

New yorkUnited statesUnited kingdomMartin varsavskyDina radenkovicGeorge churchUniversity college of londonHarvard medical schoolUniversity collegeNew york basedInsight partnersFuture venturesHarvard medical

Gameto Raises Additional $17M in Funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Clinica tambreDina radenkovicRuber internacionalGeorge churchHarvard medical schoolInsight partnersFuture venturesArcadia investment partnersBold capital partnersPlum alleyKorify capitalHarvard medicalExtend fertilityOvation fertilityHospital ruber

Gameto Announces New Funding and Preclinical Development Partnerships with Leading Global Fertility Clinics

/PRNewswire/ Gameto, a biotechnology company using cell engineering to develop therapeutics for diseases of the female reproductive system, today announced.

New yorkUnited statesMartin varsavskyClinica tambreAndrew mclaughlinAlta charoDylan morrisWarrenp knowlesDina radenkovicLeslie schrockGeorge churchRuber internacionalUniversity of wisconsinPrelude networkHarvard medical schoolInsight partners

Gameto Announces New Funding and Preclinical Development Partnerships with Leading Global Fertility Clinics

NEW YORK, Sept. 14, 2022 /PRNewswire/ Gameto, a biotechnology company using cell engineering to develop therapeutics for diseases of the female.

New yorkUnited statesCity ofUnited kingdomTel avivMartin varsavskyClinica tambreAndrew mclaughlinAlta charoDylan morrisWarrenp knowlesDina radenkovicLeslie schrockGeorge churchRuber internacionalUniversity of wisconsin

Gameto Announces New Funding and Preclinical Development Partnerships with Leading Global Fertility Clinics

/PRNewswire/ Gameto, a biotechnology company using cell engineering to develop therapeutics for diseases of the female reproductive system, today announced.

New yorkUnited statesMartin varsavskyClinica tambreAndrew mclaughlinAlta charoDylan morrisWarrenp knowlesDina radenkovicLeslie schrockGeorge churchRuber internacionalUniversity of wisconsinPrelude networkHarvard medical schoolInsight partners

vimarsana © 2020. All Rights Reserved.